The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review

International Journal of Clinical Practice
N MuszbekZ M Khan

Abstract

To review studies on the cost consequences of compliance and/or persistence in cardiovascular disease (CVD) and related conditions (hypertension, dyslipidaemia, diabetes and heart failure) published since 1995, and to evaluate the effects of noncompliance on healthcare expenditure and the cost-effectiveness of pharmaceutical interventions. English language papers published between January 1995 and February 2007 that examined compliance/persistence with medication for CVD or related conditions, provided an economic evaluation of pharmacological interventions or cost analysis, and quantified the cost consequences of noncompliance, were identified through database searches. The cost consequences of noncompliance were compared across studies descriptively. Of the 23 studies identified, 10 focused on hypertension, seven on diabetes, one on dyslipidaemia, one on coronary heart disease, one on heart failure and three covered multiple diseases. In studies assessing drug costs only, increased compliance/persistence led to increased drug costs. However, increased compliance/persistence increased the effectiveness of treatment, leading to a decrease in medical events and non-drug costs. This offset the higher drug costs, leading to saving...Continue Reading

References

Jan 1, 1996·Journal of the National Medical Association·R Hargrave, M P Remler
Oct 9, 1996·JAMA : the Journal of the American Medical Association·L B RussellM C Weinstein
Oct 6, 1998·Journal of Human Hypertension·D Hughes, A McGuire
Dec 18, 1998·The American Journal of Cardiology·D M HuseS C Hartz
Dec 9, 1995·PharmacoEconomics·T L SkaerL M Robison
Apr 29, 1999·The Journal of the American Board of Family Practice·S D RamseyE Perfetto
Dec 6, 2001·Current Hypertension Reports·J Urquhart
May 31, 2002·Journal of Human Hypertension·E Degli EspostiM Volpe
Sep 5, 2002·International Journal of Health Services : Planning, Administration, Evaluation·Eeva Ollila, Meri Koivusalo
Sep 10, 2002·Medical Care·M Robin DiMatteoThomas W Croghan
Apr 8, 2003·PharmacoEconomics·Isabelle CôtéGuy Lacroix
Dec 12, 2003·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Sabina De Geest, Eduardo Sabaté
Feb 12, 2004·The Journal of Clinical Hypertension·Luca Degli EspostiEzio Degli Esposti
Dec 16, 2004·Journal of Cardiac Failure·Ross T TsuyukiWilliam Semchuk
Jan 18, 2005·Lancet·Patricia M KearneyJiang He
Feb 8, 2005·PharmacoEconomics·Andrew M Peterson, William F McGhan
Mar 2, 2005·Annals of Internal Medicine·William H HermanUNKNOWN Diabetes Prevention Program Research Group
May 24, 2005·Medical Care·Michael C SokolRobert S Epstein
Oct 7, 2005·Journal of Hypertension·Boris Lg Van WijkAnthonius de Boer
Jan 13, 2006·Circulation·Thomas ThomUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Apr 6, 2006·Annals of Internal Medicine·Jinan B SaaddineK M Venkat Narayan
Apr 21, 2006·Journal of Managed Care Pharmacy : JMCP·Thomas J BramleyFeride Frech-Tamas
Jun 23, 2006·BMJ : British Medical Journal·Scot H SimpsonJeffrey A Johnson
Sep 27, 2006·Archives of Internal Medicine·P Michael HoDavid J Magid
Oct 27, 2006·International Journal of Clinical Pharmacology and Therapeutics·C W R ChengJ H S You
Dec 8, 2006·Annals of the New York Academy of Sciences·Ernest AdeghateEarl Dunn

❮ Previous
Next ❯

Citations

Nov 28, 2012·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·I Lanzl, T Kaercher
Mar 1, 2011·Translational Behavioral Medicine·Bonnie Spring
Jan 22, 2010·International Journal of Clinical Practice·R H ChapmanC S Roberts
Jan 22, 2010·International Journal of Clinical Practice·A Shantsila, G Y H Lip
Sep 22, 2011·ClinicoEconomics and Outcomes Research : CEOR·Luca Degli EspostiEzio Degli Esposti
Jul 23, 2013·Population Health Management·Susan E HagenDee W Edington
Feb 10, 2010·Current Medical Research and Opinion·J SignorovitchK H Kahler
Aug 9, 2012·Climacteric : the Journal of the International Menopause Society·J A Martínez PérezM Pérez
Jan 6, 2009·The Journal of Clinical Hypertension·Lemuel VawterPaula W Yoon
Oct 1, 2010·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Mohamed E E Shams, Enaase A M E Barakat
May 29, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold J BursteinJennifer J Griggs
Dec 21, 2016·Medicina clínica·José Ramón González-JuanateyIsabel Egocheaga
Dec 15, 2016·Journal of the American Pharmacists Association : JAPhA·Madhavi GaviniRichard Sadovsky
Apr 13, 2017·Internal Medicine Journal·Brooke MyersIan Coombes
Jan 7, 2011·Health Affairs·M Christopher RoebuckTroyen A Brennan
Nov 5, 2014·Australian Health Review : a Publication of the Australian Hospital Association·Tracey-Lea LabaBeverley Essue
Apr 24, 2019·Acta Medica (Hradec Králové)·Radek PelouchMiroslav Solař
Mar 28, 2019·PloS One·Amélie CransacMathieu Boulin
May 3, 2013·The Journal of Cardiovascular Nursing·Jerilyn K AllenKevin D Frick
Feb 5, 2011·Postgraduate Medicine·Joel M Neutel
Dec 5, 2013·The Journal of Clinical Hypertension·Michael A Weber
Apr 12, 2020·Aging Clinical and Experimental Research·Alessandro MonacoShaantanu Donde
Jul 16, 2009·Expert Opinion on Pharmacotherapy·Peter BramlageCaroline Hacker
Jul 12, 2017·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Francesco Vittorio Costa
Oct 24, 2020·Curēus·Jessica H RehrigChristopher Boni
Feb 13, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Seok Jin KimJuhee Cho

❮ Previous
Next ❯

Software Mentioned

ISPOR

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Hypertension
Aram V ChobanianNational High Blood Pressure Education Program Coordinating Committee
JAMA : the Journal of the American Medical Association
Merril L KnudtsonProgram to Assess Alternative Treatment Strategies to Achieve Cardiac Health (PATCH) Investigators
Diabetes Care
American Diabetes Association
© 2021 Meta ULC. All rights reserved